Caledonia (Private) Investments Pty LTD Royalty Pharma PLC Transaction History
Caledonia (Private) Investments Pty LTD
- $3.93 Billion
- Q2 2025
A detailed history of Caledonia (Private) Investments Pty LTD transactions in Royalty Pharma PLC stock. As of the latest transaction made, Caledonia (Private) Investments Pty LTD holds 6,444,729 shares of RPRX stock, worth $227 Million. This represents 5.9% of its overall portfolio holdings.
Number of Shares
6,444,729
Previous 5,114,567
26.01%
Holding current value
$227 Million
Previous $159 Million
45.84%
% of portfolio
5.9%
Previous 3.99%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
496Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.64 Billion0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA36.4MShares$1.28 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$809 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$769 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$633 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.4B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...